Actuate Therapeutics Inc
Actuate Therapeutics Inc (ACTU) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ACTU · as of Jun 9, 2026
Key Statistics
Explore Actuate Therapeutics Inc Data
actu stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
The ACTU analyst consensus is Buy, based on ratings from 1 Wall Street analysts over the past 3 months. The average 12-month price target is $21.00, representing +1053.85% upside from the current price of $1.82.
Competitors & Peers
actu competitorsACTU
ALEC
APLT
ELTX
MCRB
MOLNStock Performance
Full HistoryAbout Actuate Therapeutics Inc
Actuate Therapeutics Inc Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating treatments for various cancers. Its primary drug candidate is Elraglusib Injection, an inn…
what is actuate therapeutics inc · actu stock overview · actuate therapeutics inc company profile · who is actuate therapeutics inc ceo · actu NASDAQ · actuate therapeutics inc headquarters · actuate therapeutics inc business segments
About Stock Overview & Key Data
Actuate Therapeutics Inc (ACTU) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Aug 13, 2024. As of the latest trading session, ACTU stock price is $1.82, with a market capitalization of $43.5M. The stock has returned -79.10% over the past 12 months and -70.26% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Actuate Therapeutics Inc stock is Buy, with an average 12-month price target of $21.00. In fiscal year 2025, Actuate Therapeutics Inc reported revenue of — and net income of -$22.2M. For detailed data — including Actuate Therapeutics Inc revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Actuate Therapeutics Inc (ACTU) stock price is $1.82. The stock is traded on NASDAQ under the ticker symbol ACTU. The 52-week range is $1.58 – $9.25.